Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) insider Scott St John bought 1,543 shares of the stock in a transaction that occurred on Tuesday, June 11th. The shares were bought at an average price of A$15.42 ($10.94) per share, for a total transaction of A$23,793.06 ($16,874.51).

ASX FPH traded down A$0.18 ($0.13) on Friday, hitting A$14.24 ($10.10). 406,981 shares of the company traded hands, compared to its average volume of 371,449. The company has a market capitalization of $8.15 billion and a PE ratio of 58.12. The company has a debt-to-equity ratio of 9.51, a quick ratio of 1.63 and a current ratio of 2.47. Fisher & Paykel Healthcare Corp Ltd has a 52-week low of A$11.28 ($8.00) and a 52-week high of A$15.83 ($11.23).

The business also recently announced a Final dividend, which will be paid on Friday, July 5th. Investors of record on Friday, July 5th will be given a dividend of $0.128 per share. The ex-dividend date is Thursday, June 13th. This represents a yield of 0.88%. Fisher & Paykel Healthcare’s dividend payout ratio (DPR) is presently 106.12%.

WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/insider-buying-fisher-paykel-healthcare-corp-ltd-asxfph-insider-acquires-1543-shares-of-stock/3041743.html.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA).

Recommended Story: Quiet Period Expirations

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.